REN and heart failure: Lastly, these patients at increased risk might be eligible for preventive treatment, with either classic heart-failure treatment, such as beta-blockade or inhibition of the renin-angiotensin-aldosterone axis, or with the only FDA- and EMA- approved, but expensive, preventive drug dexrazoxane [1].